Philips And Allianz Worldwide Partners Launch Connected Health Solution And Services In Germany

Royal Philips and Allianz Worldwide Partners entered a partnership focusing on connected health solutions and services in Germany. The personal health programs* are designed for and tailored to motivate people to make healthy choices in their lifestyle, as active health management is necessary to stem the rising tide of chronic diseases. The health programs leverage Philips’ deep healthcare and consumer expertise are offered across employers as an instrument for occupational health, insurers and consumers.

“With ageing populations and in some cases poor lifestyle choices, the risk of chronic diseases are ever increasing, with significant impacts on the individuals and on the healthcare system,” said Caroline Clarke, CEO Population Health Management at Philips. “We want to help people take more control over their health.”

Participants in the Philips personal health programs receive one or more devices, a smart phone app, digital content, and regular coaching sessions from Allianz Global Assistance, the German entity of Allianz Worldwide Partners. These coaching calls are conducted by a healthcare professional, such as a doctor, a nutritionist or a physiologist depending on the program. The healthcare professionals give participants the chance to get more insight into their lifestyle and get personal advice and help change their habits.

“Our multi-modal prevention programs combine modern Philips technology and digital know how with personalized coaching programs and aim at sustainable lifestyle change in the fields of nutrition, exercise and stress management, which are widely accepted as the key to prevent chronic diseases,” said Dr. Steffen Krotsch, Head of Innovation, Allianz Worldwide Partners. “The coaching adds the personal touch, education on medical topics and friendly reminders to sustain the improved lifestyle.”

The health measurement devices that gather information for the Philips personal health programs are all Bluetooth enabled, connecting wirelessly to the Philips HealthSuite Health app so users can conveniently track their measurements over time. They form part of Philips’ connected health propositions that all link through the Philips HealthSuite digital platform, an open and secure platform that collects and analyzes health and other data from multiple devices and sources.

The health measurement devices used for the programs include:

• The Philips Health band – empowers you to live a healthier life by tracking your activity, heart rate and sleep

• The Philips wrist blood pressure monitor – a compact and easy-to-carry device that allows you to measure your systolic & diastolic blood pressure as well as your heart rate. Is rechargeable via USB.

• The Philips body analysis scale – an elegant device that measures weight, estimates body fat through Bio-Impedance Analysis, and calculates BMI. Supports the entire family with up to eight user profiles.

*The Philips health programs and health measurement devices are not currently available for sale in the USA.

Read more...

Philips Enters New Agreement On Patient Monitoring Systems And Software With The Stockholm County Council

Philips enters new agreement on patient monitoring systems and software with the Stockholm County Council

Royal Philips announced that it has signed a new agreement with the Stockholm County Council on patient monitoring systems and software for the Karolinska University Hospital, which comprises the New Karolinska Solna University Hospital and the Karolinska University Hospital Huddinge.

As part of the agreement, Philips will deliver patient monitoring systems and clinical decision support applications that can be used to monitor a patient’s vital signs including the respiratory rate, pulse, blood pressure and temperature.

“The deterioration of a patient’s condition is often preceded by physiological changes that can be detected up to 24 hours before a serious event,” said Håkan Skytt, Customer Manager at Philips Sweden. “Changes in a patient’s vital signs are frequently an indication that the patient’s condition is worsening and that there is an increased risk of complications. Constant monitoring of the vital signs will allow any subtle changes to be detected and addressed in a timely manner.”

The new agreement further includes an innovation collaboration to jointly develop next-generation solutions for patient-centric care.

“For Philips, strategic partnerships with leading healthcare providers such as Karolinka University Hospital are an important and effective way to create innovative health technologies that can both streamline and enhance the delivery of care,” said Johan Folkunger, General Manager of Philips’ Health Systems businesses in Sweden.

Philips’ patient monitoring systems can measure and collect a patient’s vital signs and allow remote monitoring from a central workstation as well as bedside monitoring at an individual patient’s bedside. The data can be readily accessed and used by the relevant staff for the adequate delivery of care.

The collected data is stored centrally at the Karolinska University Hospital and can be used for the delivery of care, quality enhancement and clinical research. The New Karolinska Solna University Hospital is currently being constructed and will be admitting the first patients in the fourth quarter of 2016. The majority of the construction work is expected to be finalized in the course of 2017 and the hospital is planned to be fully operational in 2018. Karolinska University Hospital is one of the world’s leading academic hospitals, and its new site will reinforce its position in the field of highly specialized medical care.

The New Karolinska Solna University Hospital will implement a patient-centric approach to healthcare and deploy care pathways in which patient care, clinical research and training have been integrated. This is fully in line with Philips’ mission to develop meaningful innovations that make a difference for consumers, patients and healthcare providers.

 

Read more...

Philips and Eindhoven University of Technology measure and visualize local chemotherapy delivery to tumors

Royal Philips Electronics (AEX: PHI, NYSE: PHG) and Eindhoven University of Technology (TU/e) announced an important development today in MRI-guided local drug delivery for cancer treatment.

Image-guided drug delivery has been studied by scientists all around the world for almost a decade because it may enable a beneficial increase in tumor chemotherapy drug levels, thereby increasing treatment efficacy without an increase in adverse side effects. The joint research team has now demonstrated in pre-clinical studies that an improved local drug uptake in tumors is achieved, and that it can be visualized and measured in real time. These measurements may give an indication at time of delivery if drug uptake in the tumor was sufficient, or if an additional treatment may be needed. This proof of concept will appear in the Journal of Controlled Release in February (de Smet et al., Journal of Controlled Release 150 (1), 102-110 (2011)).

Read more...
Subscribe to this RSS feed